Cargando…

Single Versus Double Dose Praziquantel Comparison on Efficacy and Schistosoma mansoni Re-Infection in Preschool-Age Children in Uganda: A Randomized Controlled Trial

BACKGROUND: Schistosoma mansoni infection is proven to be a major health problem of preschool-age children in sub-Saharan Africa, yet this age category is not part of the schistosomiasis control program. The objective of this study was to compare the impact of single and double dose praziquantel (PZ...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nalugwa, Allen, Nuwaha, Fred, Tukahebwa, Edridah Muheki, Olsen, Annette
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4444284/ https://www.ncbi.nlm.nih.gov/pubmed/26011733 http://dx.doi.org/10.1371/journal.pntd.0003796

Ejemplares similares

Regression of Schistosoma mansoni associated morbidity among Ugandan preschool children following praziquantel treatment: A randomised trial
por: Nalugwa, Allen, et al.
Publicado: (2021)

Schistosoma mansoni-Associated Morbidity among Preschool-Aged Children along the Shores of Lake Victoria in Uganda
por: Nalugwa, Allen, et al.
Publicado: (2017)

Increasing teacher motivation and supervision is an important but not sufficient strategy for improving praziquantel uptake in Schistosoma mansoni control programs: serial cross sectional surveys in Uganda
por: Muhumuza, Simon, et al.
Publicado: (2013)

Low Praziquantel Treatment Coverage for Schistosoma mansoni in Mayuge District, Uganda, Due to the Absence of Treatment Opportunities, Rather Than Systematic Non-Compliance
por: Adriko, Moses, et al.
Publicado: (2018)

Reduced Efficacy of Praziquantel Against Schistosoma mansoni Is Associated With Multiple Rounds of Mass Drug Administration
por: Crellen, Thomas, et al.
Publicado: (2016)

Residence Time, Water Contact, and Age-driven Schistosoma mansoni Infection in Hotspot Communities in Uganda
por: Moses, Arinaitwe, et al.
Publicado: (2021)

Two-year longitudinal survey reveals high genetic diversity of Schistosoma mansoni with adult worms surviving praziquantel treatment at the start of mass drug administration in Uganda
por: Faust, Christina L., et al.
Publicado: (2019)

Praziquantel-encapsulated niosomes against Schistosoma mansoni with reduced sensitivity to praziquantel
por: Amer, Eglal I., et al.
Publicado: (2022)

THE SUSCEPTIBILITY OF RECENT ISOLATES OF Schistosoma mansoni TO PRAZIQUANTEL
por: MENDONÇA, Adriana Maria B., et al.
Publicado: (2016)

A Very High Infection Intensity of Schistosoma mansoni in a Ugandan Lake Victoria Fishing Community Is Required for Association with Highly Prevalent Organ Related Morbidity
por: Tukahebwa, Edridah M., et al.
Publicado: (2013)

Efficacy and Safety of Praziquantel in Preschool-Aged Children in an Area Co-Endemic for Schistosoma mansoni and S. haematobium
por: Coulibaly, Jean T., et al.
Publicado: (2012)

Understanding the relationship between egg- and antigen-based diagnostics of Schistosoma mansoni infection pre- and post-treatment in Uganda
por: Prada, Joaquín M., et al.
Publicado: (2018)

Risk assessment for the implementation of controlled human Schistosoma mansoni infection trials in Uganda
por: Koopman, Jan Pieter, et al.
Publicado: (2019)

Impacts of host gender on Schistosoma mansoni risk in rural Uganda—A mixed-methods approach
por: Trienekens, Suzan C. M., et al.
Publicado: (2020)

Human IgG(1) Responses to Surface Localised Schistosoma mansoni Ly6 Family Members Drop following Praziquantel Treatment
por: Chalmers, Iain W., et al.
Publicado: (2015)

Praziquantel efficacy against Schistosoma mansoni among HIV-1 infected and uninfected adults living in fishing villages along Lake Victoria, Northwest Tanzania
por: Mazigo, Humphrey D, et al.
Publicado: (2014)

The Role of Efflux Pumps in Schistosoma mansoni Praziquantel Resistant Phenotype
por: Pinto-Almeida, António, et al.
Publicado: (2015)

Investigations on the interplays between Schistosoma mansoni, praziquantel and the gut microbiome
por: Schneeberger, Pierre H. H., et al.
Publicado: (2018)

A single locus determines praziquantel response in Schistosoma mansoni
por: Chevalier, Frédéric D., et al.
Publicado: (2023)

Variation in water contact behaviour and risk of Schistosoma mansoni (re)infection among Ugandan school-aged children in an area with persistent high endemicity
por: Trienekens, Suzan C. M., et al.
Publicado: (2022)

Effect of water temperature and population density on the population dynamics of Schistosoma mansoni intermediate host snails
por: McCreesh, Nicky, et al.
Publicado: (2014)

Schistosoma mansoni infection among preschool age children attending Erer Health Center, Ethiopia and the response rate to praziquantel
por: Kemal, Makida, et al.
Publicado: (2019)

Efficacy of Single-Dose Praziquantel for the Treatment of Schistosoma mansoni Infections among School Children in Rwanda
por: Kabatende, Joseph, et al.
Publicado: (2023)

Praziquantel Treatment Decreases Schistosoma mansoni Genetic Diversity in Experimental Infections
por: Coeli, Regina, et al.
Publicado: (2013)

Evaluation of the pharmacokinetic-pharmacodynamic relationship of praziquantel in the Schistosoma mansoni mouse model
por: Abla, Nada, et al.
Publicado: (2017)

Effect of Dihydroartemisinin-Piperaquine on the Pharmacokinetics of Praziquantel for Treatment of Schistosoma mansoni Infection
por: Minzi, Omary Mashiku, et al.
Publicado: (2021)

Influence of Schistosoma mansoni and Hookworm Infection Intensities on Anaemia in Ugandan Villages
por: Chami, Goylette F., et al.
Publicado: (2015)

Schistosoma mansoni infection risk for school-aged children clusters within households and is modified by distance to freshwater bodies
por: Lamberti, Olimpia, et al.
Publicado: (2021)

Observed Reductions in Schistosoma mansoni Transmission from Large-Scale Administration of Praziquantel in Uganda: A Mathematical Modelling Study
por: French, Michael D., et al.
Publicado: (2010)

Evaluation of Schistosoma Mansoni Morbidity One Year After Praziquantel Treatment in Rhino Camp and Obongi in West Nile, Uganda
por: Odongo-Aginya, E I, et al.
Publicado: (2010)

Correction: Influence of Schistosoma mansoni and Hookworm Infection Intensities on Anaemia in Ugandan Villages
por: Chami, Goylette F., et al.
Publicado: (2015)

Interpreting ambiguous ‘trace’ results in Schistosoma mansoni CCA Tests: Estimating sensitivity and specificity of ambiguous results with no gold standard
por: Clements, Michelle N., et al.
Publicado: (2017)

Antibody responses to Schistosoma mansoni schistosomula antigens
por: Egesa, Moses, et al.
Publicado: (2018)

Exploring Gender Dimensions of Treatment Programmes for Neglected Tropical Diseases in Uganda
por: Rilkoff, Heather, et al.
Publicado: (2013)

Reduced Susceptibility to Praziquantel among Naturally Occurring Kenyan Isolates of Schistosoma mansoni
por: Melman, Sandra D., et al.
Publicado: (2009)

Synergy of Omeprazole and Praziquantel In Vitro Treatment against Schistosoma mansoni Adult Worms
por: Almeida, Giulliana T., et al.
Publicado: (2015)

Praziquantel–lipid nanocapsules: an oral nanotherapeutic with potential Schistosoma mansoni tegumental targeting
por: Amara, Rokaya O, et al.
Publicado: (2018)

Establishing a single-sex controlled human Schistosoma mansoni infection model for Uganda: protocol for safety and dose-finding trial
por: Abaasa, Andrew, et al.
Publicado: (2023)

Efficacy and safety of praziquantel in preschool-aged and school-aged children infected with Schistosoma mansoni: a randomised controlled, parallel-group, dose-ranging, phase 2 trial
por: Coulibaly, Jean T, et al.
Publicado: (2017)

Data on the pre-MDA and post MDA interventions for Schistosoma mansoni and Schistosoma haematobium in a co-endemic focus in Uganda: 1951–2011
por: Adriko, M., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_49t9uvcmkpv4j77np9dail5tqt